Wolchok JD - Search Results

1

Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications.

Su YB, Sohn S, Krown SE, Livingston PO, Wolchok JD, Quinn C, Williams L, Foster T, Sepkowitz KA, Chapman PB. Su YB, et al. Among authors: wolchok jd. J Clin Oncol. 2004 Feb 15;22(4):610-6. doi: 10.1200/JCO.2004.07.060. Epub 2004 Jan 15. J Clin Oncol. 2004. PMID: 14726505

2

Vaccines and other adjuvant therapies for melanoma.

Wolchok JD, Livingston PO, Houghton AN. Wolchok JD, et al. Hematol Oncol Clin North Am. 1998 Aug;12(4):835-48, vii. doi: 10.1016/s0889-8588(05)70026-5. Hematol Oncol Clin North Am. 1998. PMID: 9759582 Review.

3

Prophylactic recombinant epoetin alfa markedly reduces the need for blood transfusion in patients with metastatic melanoma treated with biochemotherapy.

Wolchok JD, Klimek VM, Williams L, Chapman PB. Wolchok JD, et al. Cytokines Cell Mol Ther. 1999 Dec;5(4):205-6. Cytokines Cell Mol Ther. 1999. PMID: 10850383

4

Systemic chemotherapy.

Klimek VM, Wolchok JD, Chapman PB, Houghton AN, Hwu WJ. Klimek VM, et al. Among authors: wolchok jd. Clin Plast Surg. 2000 Jul;27(3):451-61, ix-x. Clin Plast Surg. 2000. PMID: 10941565 Review.

5

Vaccines for melanoma: translating basic immunology into new therapies.

Wolchok JD, Livingston PO. Wolchok JD, et al. Lancet Oncol. 2001 Apr;2(4):205-11. doi: 10.1016/s1470-2045(00)00290-4. Lancet Oncol. 2001. PMID: 11905765 Review.

6

Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope.

Wolchok JD, Chapman PB. Wolchok JD, et al. J Clin Oncol. 2002 Jul 15;20(14):3176; author reply 3176-7. doi: 10.1200/JCO.2002.20.14.3176. J Clin Oncol. 2002. PMID: 12118032 No abstract available.

7

Clinical results using biochemotherapy as a standard of care in advanced melanoma.

Chapman PB, Panageas KS, Williams L, Wolchok JD, Livingston PO, Quinn C, Hwu WJ. Chapman PB, et al. Among authors: wolchok jd. Melanoma Res. 2002 Aug;12(4):381-7. doi: 10.1097/00008390-200208000-00011. Melanoma Res. 2002. PMID: 12170188

8

How can we tell when cancer vaccines vaccinate?

Wolchok JD, Chapman PB. Wolchok JD, et al. J Clin Oncol. 2003 Feb 15;21(4):586-7. doi: 10.1200/JCO.2003.12.065. J Clin Oncol. 2003. PMID: 12586792 No abstract available.

9

Phase I trial of high dose paracetamol and carmustine in patients with metastatic melanoma.

Wolchok JD, Williams L, Pinto JT, Fleisher M, Krown SE, Hwu WJ, Livingston PO, Chang C, Chapman PB. Wolchok JD, et al. Melanoma Res. 2003 Apr;13(2):189-96. doi: 10.1097/00008390-200304000-00013. Melanoma Res. 2003. PMID: 12690304 Clinical Trial.

10

Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling.

Segal NH, Pavlidis P, Noble WS, Antonescu CR, Viale A, Wesley UV, Busam K, Gallardo H, DeSantis D, Brennan MF, Cordon-Cardo C, Wolchok JD, Houghton AN. Segal NH, et al. Among authors: wolchok jd. J Clin Oncol. 2003 May 1;21(9):1775-81. doi: 10.1200/JCO.2003.10.108. J Clin Oncol. 2003. PMID: 12721254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

471 results

Search Page